Solid Tumor
1,054
274
346
354
Key Insights
Highlights
Success Rate
72% trial completion
Published Results
119 trials with published results (11%)
Research Maturity
354 completed trials (34% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.0%
137 terminated out of 1054 trials
72.1%
-14.4% vs benchmark
1%
11 trials in Phase 3/4
34%
119 of 354 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 354 completed trials
Clinical Trials (1054)
A Study of ASP3082 in Adults With Advanced Solid Tumors
NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
A Study of DS-3939a in Participants With Solid Tumors
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Atamparib in Patients With Advanced Solid Tumors
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid Tumors
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
Study of GS-4528 in Adults With Solid Tumors
A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
A Dose Finding Study to Treat Bone Tumor(s)
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors